DRIO
DarioHealth Corp
5.40$
-10.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | 2.12 | 8.67 | 10.77 | 10.74 | 6.32 | 3.34 | 1.27 | 1.24 | 1.17 | 0.72 | 0.67 | 0.45 | |
| – | 1,333.04 | 94.33 | 17.68 | 12.93 | 8.02 | 4.81 | 2.19 | 0.85 | 0.75 | 0.76 | 0.51 | 0.34 | 0.20 | |
| – | -1,333.04 | -92.21 | -9.01 | -2.16 | 2.72 | 1.51 | 1.15 | 0.42 | 0.49 | 0.41 | 0.21 | 0.33 | 0.26 | |
| 135.36 | 482.84 | 163.56 | 27.03 | 8.28 | 6.85 | 3.14 | 1.63 | 0.74 | 1.04 | 0.83 | 0.71 | 0.60 | 0.28 | |
| 196.30 | 618.79 | 150.99 | 31.07 | 12.98 | 9.82 | 4.67 | 2.42 | 2.14 | 1.37 | 0.70 | 0.63 | 0.51 | 0.31 | |
| 358.35 | 1,333.04 | 358.64 | 72.12 | 39.48 | 32.67 | 16.62 | 8.96 | 5.44 | 5.10 | 2.81 | 2.19 | 1.76 | 0.99 | |
| -358.35 | -1,333.04 | -471.13 | -81.13 | -42.67 | -29.95 | -15.11 | -7.81 | -5.01 | -4.61 | -2.40 | -1.98 | -1.43 | -0.74 | |
| 0.00 | 7.45 | 152.65 | 0.23 | 0.08 | 0.36 | 0.02 | 0.01 | 0.01 | 0.01 | 0.11 | 0.02 | 0.00 | 0.07 | |
| -512.72 | -1,369.35 | -534.14 | -75.27 | -41.85 | -32.70 | -15.21 | -7.83 | -4.94 | -4.62 | -2.63 | -2.09 | -1.10 | -0.84 | |
| 154.37 | 36.31 | 83.29 | -5.86 | 0.21 | 2.75 | -0.10 | 0.01 | -0.08 | 0.00 | 0.00 | 0.00 | -0.05 | 0.00 | |
| -512.72 | -1,369.35 | -534.14 | -75.27 | -41.85 | -32.70 | -15.21 | -7.83 | -4.94 | -4.63 | -2.63 | -2.09 | -1.06 | -0.84 | |
| -211.32 | -1,286.86 | -428.07 | -77.60 | -40.15 | -29.55 | -14.93 | -7.73 | -4.98 | -4.22 | -2.35 | -1.92 | -0.92 | -0.70 |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.